Suppr超能文献

囊泡运输调节因子是乳腺癌进展中的新角色:TOM1L1在ERBB2依赖性侵袭中的作用

Vesicular trafficking regulators are new players in breast cancer progression: Role of TOM1L1 in ERBB2-dependent invasion.

作者信息

Chevalier Clément, Roche Serge, Bénistant Christine

机构信息

Centre de Recherche de Biologie Cellulaire de Montpellier, Equipe labellisée Ligue Contre le Cancer, CNRS UMR 5237 , Montpellier, France.

Centre de Recherche de Biologie Cellulaire de Montpellier, Equipe labellisée Ligue Contre le Cancer, CNRS UMR 5237, Montpellier, France; Centre de Biochimie Structurale, CNRS UMR 5048-INSERM UMR 1054, Montpellier, France.

出版信息

Mol Cell Oncol. 2016 Apr 28;3(4):e1182241. doi: 10.1080/23723556.2016.1182241. eCollection 2016 Jul.

Abstract

ERBB2 (v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2) amplification is associated with invasive breast cancer. We discovered that TOM1L1 (target of myb1-like 1) and ERBB2 co-amplification defines a novel mechanism involved in breast cancer metastatic progression. Upregulation of the vesicular trafficking protein TOM1L1 enhances plasma membrane delivery of membrane-type 1 matrix metalloprotease (MT1-MMP) for efficient extracellular matrix degradation and tumor cell dissemination.

摘要

ERBB2(v-erb-b2禽成红细胞白血病病毒癌基因同源物2)扩增与浸润性乳腺癌相关。我们发现TOM1L1(类Myb1靶点1)与ERBB2共同扩增定义了一种参与乳腺癌转移进展的新机制。囊泡运输蛋白TOM1L1的上调增强了膜型1基质金属蛋白酶(MT1-MMP)向质膜的转运,从而有效地降解细胞外基质并促进肿瘤细胞播散。

相似文献

1
Vesicular trafficking regulators are new players in breast cancer progression: Role of TOM1L1 in ERBB2-dependent invasion.
Mol Cell Oncol. 2016 Apr 28;3(4):e1182241. doi: 10.1080/23723556.2016.1182241. eCollection 2016 Jul.
3
ERBB2 oncogenicity: ERBIN helps to perform the job.
Mol Cell Oncol. 2015 Mar 19;2(3):e995033. doi: 10.4161/23723556.2014.995033. eCollection 2015 Jul-Sep.
4
MiR-34a modulates ErbB2 in breast cancer.
Cell Biol Int. 2017 Jan;41(1):93-101. doi: 10.1002/cbin.10700. Epub 2016 Dec 1.
5
Regulation of the MIR155 host gene in physiological and pathological processes.
Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14.
6
CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.
Mol Cancer Res. 2013 Jun;11(6):628-37. doi: 10.1158/1541-7786.MCR-12-0544. Epub 2013 Feb 25.
8
Irreversible tyrosine kinase inhibitors induce the endocytosis and downregulation of ErbB2.
Biochem Biophys Rep. 2023 Feb 6;34:101436. doi: 10.1016/j.bbrep.2023.101436. eCollection 2023 Jul.
9
MT1-MMP targeting to endolysosomes is mediated by upregulation of flotillins.
J Cell Sci. 2018 Sep 5;131(17):jcs218925. doi: 10.1242/jcs.218925.

引用本文的文献

2
TOM1L1 mediated the sort of tumor suppressive miR-378a-3p into exosomes and the excretion out of cells to promote ESCC progression.
Cancer Gene Ther. 2025 May;32(5):507-520. doi: 10.1038/s41417-025-00889-6. Epub 2025 Mar 23.
6
Regulation of MT1-MMP Activity through Its Association with ERMs.
Cells. 2020 Feb 3;9(2):348. doi: 10.3390/cells9020348.
7
Vesicular trafficking-related proteins as the potential therapeutic target for breast cancer.
Protoplasma. 2020 Mar;257(2):345-352. doi: 10.1007/s00709-019-01462-3. Epub 2019 Dec 11.

本文引用的文献

4
The emerging role of VHS domain-containing Tom1, Tom1L1 and Tom1L2 in membrane trafficking.
Traffic. 2010 Sep;11(9):1119-28. doi: 10.1111/j.1600-0854.2010.01098.x. Epub 2010 Jul 1.
5
Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.
J Cell Sci. 2009 Sep 1;122(Pt 17):3015-24. doi: 10.1242/jcs.034561.
6
The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors.
Mol Cell Biol. 2006 Mar;26(5):1932-47. doi: 10.1128/MCB.26.5.1932-1947.2006.
8
'Srcasm: a novel Src activating and signaling molecule.
J Biol Chem. 2002 Jan 25;277(4):2812-22. doi: 10.1074/jbc.M106813200. Epub 2001 Nov 15.
9
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer.
Oncogene. 2000 Dec 11;19(53):6102-14. doi: 10.1038/sj.onc.1203973.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验